You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search


( ROE-mi-DEP sin )
New Drug Funding Program
  • Romidepsin - Relapsed or Refractory Peripheral T-Cell Lymphoma
Other Name(s): Istodax® (Celgene)
Appearance: Clear, colourless solution mixed into larger bags of fluids

Patient Info Sheet

May 2018

What it is used for

• For treating a certain type of lymphoma (peripheral T-cell lymphoma) in patients who have received a previous treatment and who cannot receive a stem cell transplant

You might also be interested in